Cargando…

An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer’s Disease Therapeutic Development

Cannabidiol (CBD), a major non-psychoactive component of the cannabis plant, has shown therapeutic potential in Alzheimer’s disease (AD). In this study, we identified potential CBD targets associated with AD using a drug-target binding affinity prediction model and generated CBD analogs using a gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Kyudam, Lee, Yurim, Kim, Cheongwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648567/ https://www.ncbi.nlm.nih.gov/pubmed/37959001 http://dx.doi.org/10.3390/ijms242116013

Ejemplares similares

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
por: Watt, Georgia, et al.
Publicado: (2017)

Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
por: Xiong, Yinyi, et al.
Publicado: (2021)

Cannabidiol attenuates inflammatory impairment of intestinal cells expanding biomaterial-based therapeutic approaches
por: Boehm, Elisa, et al.
Publicado: (2023)

The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer’s Disease
por: Trojan, Václav, et al.
Publicado: (2023)

The therapeutic potential of purified cannabidiol
por: O’Sullivan, Saoirse Elizabeth, et al.
Publicado: (2023)

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches
por: Cruz-Vicente, Pedro, et al.
Publicado: (2021)

The Expanding Therapeutic Utility of Botulinum Neurotoxins
por: Fonfria, Elena, et al.
Publicado: (2018)

Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications
por: Assadpour, Elham, et al.
Publicado: (2023)

The pharmacology and therapeutic role of cannabidiol in diabetes
por: Zhang, Jin, et al.
Publicado: (2023)

Cannabidiol in Humans—The Quest for Therapeutic Targets
por: Zhornitsky, Simon, et al.
Publicado: (2012)

Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
por: Nahler, Gerhard
Publicado: (2022)

In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells
por: Kim, Jungnam, et al.
Publicado: (2021)

Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
por: Contin, Manuela, et al.
Publicado: (2021)

Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells
por: Libro, Rosaliana, et al.
Publicado: (2016)

Cannabidiol as a Novel Therapeutic for Immune Modulation
por: Peyravian, Nadia, et al.
Publicado: (2020)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
por: Viana, Milena de Barros, et al.
Publicado: (2022)

The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol
por: Oliveira, Bruna Stefane Alves de, et al.
Publicado: (2022)

Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
por: Yau, Grace Tsz Yan, et al.
Publicado: (2023)

Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
por: Kim, Jung Lim, et al.
Publicado: (2019)

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
por: Hayakawa, Kazuhide, et al.
Publicado: (2010)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
por: Baswan, Sudhir M, et al.
Publicado: (2020)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study
por: Razavi, Yasaman, et al.
Publicado: (2021)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model
por: Chesworth, Rose, et al.
Publicado: (2022)

In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer’s disease
por: Satarker, Sairaj, et al.
Publicado: (2021)

Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors
por: Lim, Joline S. J., et al.
Publicado: (2017)

Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol
por: Storozhuk, Maksim V.
Publicado: (2023)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
por: Fortin, Davide, et al.
Publicado: (2021)

The therapeutic role of Cannabidiol in mental health: a systematic review
por: Khan, Rabia, et al.
Publicado: (2020)

Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent
por: Aebersold, Alyssa, et al.
Publicado: (2021)

Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction
por: Blanton, Henry, et al.
Publicado: (2022)

Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease
por: Gusho, Charles A, et al.
Publicado: (2020)

Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
por: Patricio, Felipe, et al.
Publicado: (2020)

Recent developments in Alzheimer's disease therapeutics
por: Rafii, Michael S, et al.
Publicado: (2009)

Therapeutics of Alzheimer’s Disease: Recent Developments
por: Burns, Scott, et al.
Publicado: (2022)

Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models
por: Domingos, Luana B., et al.
Publicado: (2022)

In silico analysis of binding interaction of conantokins with NMDA receptors for potential therapeutic use in Alzheimer’s disease
por: Waqar, Maleeha, et al.
Publicado: (2017)

Evaluation of selected carotenoids of Lycopersicon esculentum variants as therapeutic targets for ‘Alzheimer’s disease: an in silico approach
por: Bakare, Olalekan Olanrewaju, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5utcpup10d0p6bf77kf93h9cs4